A small drug development company that moved its headquarters last year from Cambridge, MA to the BioCT Innovations Commons on Shennecossett Road in Groton, is aiming to have a huge impact on the treatment of strokes and brain injuries.
Co-founded by William Korinek of Stonington, who spent nearly a decade at Pfizer, Astrocyte Pharmaceuticals expects to launch a phase one clinical trial of its leading drug candidate in the first half of 2022.